Business Context and Reporting Period
This Form 8-K Current Report was filed by Core Laboratories Inc. (NYSE: CLB) on February 27, 2026. The report addresses corporate governance amendments approved by the Board of Directors on the same date.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate bylaw amendments and does not contain financial performance data.
Material Changes
The Board of Directors approved and adopted the First Amended and Restated Bylaws, effective February 27, 2026. The sole material change is the reduction of the voting threshold in Section 2.11 for certain shareholder actions, including merger and change in control transactions. The threshold was lowered from a 66-2/3% supermajority vote to a 50% plus one simple majority vote.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. No specific risks or contingencies are disclosed in this document other than the procedural change to shareholder voting requirements.
Key Facts for Investor Verification
- The voting threshold for mergers and change in control transactions has been reduced to a simple majority (50% + 1).
- The amendment was approved by the Board of Directors on February 27, 2026.
- The complete text of the First Amended and Restated Bylaws is attached as Exhibit 3.1.
- No financial results or operational updates are included in this filing.